Rank | Gene Set | Z-score |
---|---|---|
1 | axon ensheathment in central nervous system (GO:0032291) | 9.57016088 |
2 | central nervous system myelination (GO:0022010) | 9.57016088 |
3 | centriole replication (GO:0007099) | 8.34400694 |
4 | positive regulation of histone deacetylation (GO:0031065) | 6.86141056 |
5 | N-acetylneuraminate metabolic process (GO:0006054) | 6.72658078 |
6 | regulation of MHC class II biosynthetic process (GO:0045346) | 6.26002080 |
7 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 6.20120667 |
8 | centriole assembly (GO:0098534) | 5.76174598 |
9 | cellular extravasation (GO:0045123) | 5.28809443 |
10 | regulation of helicase activity (GO:0051095) | 5.13218681 |
11 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.98991048 |
12 | positive regulation of protein deacetylation (GO:0090312) | 4.73018593 |
13 | neuromuscular process controlling posture (GO:0050884) | 4.69725119 |
14 | base-excision repair, AP site formation (GO:0006285) | 4.58309713 |
15 | negative regulation of neurotransmitter transport (GO:0051589) | 4.57227329 |
16 | establishment of mitochondrion localization (GO:0051654) | 4.56916070 |
17 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.55252298 |
18 | cytokinetic process (GO:0032506) | 4.53901346 |
19 | thalamus development (GO:0021794) | 4.53288018 |
20 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.48528566 |
21 | axon ensheathment (GO:0008366) | 4.47268364 |
22 | ensheathment of neurons (GO:0007272) | 4.47268364 |
23 | myelination (GO:0042552) | 4.45031733 |
24 | myelin maintenance (GO:0043217) | 4.38663190 |
25 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.30939687 |
26 | fatty acid elongation (GO:0030497) | 4.28189701 |
27 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.20784276 |
28 | fucose catabolic process (GO:0019317) | 4.18772646 |
29 | L-fucose metabolic process (GO:0042354) | 4.18772646 |
30 | L-fucose catabolic process (GO:0042355) | 4.18772646 |
31 | amino sugar catabolic process (GO:0046348) | 4.18490261 |
32 | protein neddylation (GO:0045116) | 4.17538329 |
33 | microglial cell activation (GO:0001774) | 4.14901130 |
34 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 4.13966344 |
35 | presynaptic membrane organization (GO:0097090) | 4.11834132 |
36 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.11160001 |
37 | N-acetylglucosamine metabolic process (GO:0006044) | 4.03689661 |
38 | epithelial cilium movement (GO:0003351) | 3.98920911 |
39 | leukotriene biosynthetic process (GO:0019370) | 3.88321292 |
40 | nonmotile primary cilium assembly (GO:0035058) | 3.87991583 |
41 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.81700674 |
42 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.81700674 |
43 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.81592252 |
44 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.77776163 |
45 | regulation of chemokine biosynthetic process (GO:0045073) | 3.77118907 |
46 | negative regulation of acute inflammatory response (GO:0002674) | 3.76026979 |
47 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.73976581 |
48 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.73976581 |
49 | regulation of histone deacetylation (GO:0031063) | 3.73123285 |
50 | L-amino acid import (GO:0043092) | 3.71916073 |
51 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.70750179 |
52 | cellular response to cadmium ion (GO:0071276) | 3.64306557 |
53 | limb bud formation (GO:0060174) | 3.63949472 |
54 | dopamine biosynthetic process (GO:0042416) | 3.60011012 |
55 | reactive oxygen species biosynthetic process (GO:1903409) | 3.55754036 |
56 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.51812624 |
57 | chaperone-mediated protein transport (GO:0072321) | 3.49642367 |
58 | creatine metabolic process (GO:0006600) | 3.47350392 |
59 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.44432682 |
60 | cellular response to oxygen radical (GO:0071450) | 3.39749712 |
61 | removal of superoxide radicals (GO:0019430) | 3.39749712 |
62 | cellular response to superoxide (GO:0071451) | 3.39749712 |
63 | L-phenylalanine catabolic process (GO:0006559) | 3.36232943 |
64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.36232943 |
65 | negative regulation of protein localization to cell surface (GO:2000009) | 3.33492542 |
66 | oligodendrocyte differentiation (GO:0048709) | 3.32518959 |
67 | glomerular visceral epithelial cell development (GO:0072015) | 3.29784987 |
68 | eye photoreceptor cell differentiation (GO:0001754) | 3.27656871 |
69 | photoreceptor cell differentiation (GO:0046530) | 3.27656871 |
70 | somite rostral/caudal axis specification (GO:0032525) | 3.26622290 |
71 | negative regulation of amino acid transport (GO:0051956) | 3.26315197 |
72 | response to methylmercury (GO:0051597) | 3.25240214 |
73 | ventricular system development (GO:0021591) | 3.24629250 |
74 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.23252372 |
75 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.23252372 |
76 | early endosome to late endosome transport (GO:0045022) | 3.19426337 |
77 | response to redox state (GO:0051775) | 3.15746569 |
78 | cilium movement (GO:0003341) | 3.12519130 |
79 | regulation of growth of symbiont in host (GO:0044126) | 3.11762979 |
80 | negative regulation of growth of symbiont in host (GO:0044130) | 3.11762979 |
81 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.11762979 |
82 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.11762979 |
83 | response to misfolded protein (GO:0051788) | 3.09254393 |
84 | ovulation from ovarian follicle (GO:0001542) | 3.06872135 |
85 | imidazole-containing compound metabolic process (GO:0052803) | 3.06732674 |
86 | protein polyglutamylation (GO:0018095) | 3.06516173 |
87 | import into cell (GO:0098657) | 3.04816373 |
88 | response to oxygen radical (GO:0000305) | 3.03384793 |
89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03317547 |
90 | detection of temperature stimulus (GO:0016048) | 3.03237343 |
91 | pyrimidine dimer repair (GO:0006290) | 3.02109209 |
92 | seminiferous tubule development (GO:0072520) | 3.02076298 |
93 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.02059835 |
94 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.02059835 |
95 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.01912279 |
96 | detection of light stimulus involved in visual perception (GO:0050908) | 3.01912279 |
97 | enteric nervous system development (GO:0048484) | 2.98331174 |
98 | adult walking behavior (GO:0007628) | 2.97424590 |
99 | prenylation (GO:0097354) | 2.97291494 |
100 | protein prenylation (GO:0018342) | 2.97291494 |
101 | axoneme assembly (GO:0035082) | 2.96320969 |
102 | male meiosis (GO:0007140) | 2.96243900 |
103 | regulation of lipoprotein metabolic process (GO:0050746) | 2.95021509 |
104 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.94834176 |
105 | nucleotide transmembrane transport (GO:1901679) | 2.94641375 |
106 | presynaptic membrane assembly (GO:0097105) | 2.94401783 |
107 | aldehyde catabolic process (GO:0046185) | 2.92875290 |
108 | nerve growth factor signaling pathway (GO:0038180) | 2.91480629 |
109 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.88683520 |
110 | photoreceptor cell maintenance (GO:0045494) | 2.88631594 |
111 | glomerular epithelial cell development (GO:0072310) | 2.85589196 |
112 | apical protein localization (GO:0045176) | 2.85043153 |
113 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.83210107 |
114 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.82084877 |
115 | mating behavior (GO:0007617) | 2.80666133 |
116 | transcription from mitochondrial promoter (GO:0006390) | 2.80235933 |
117 | reciprocal DNA recombination (GO:0035825) | 2.79652963 |
118 | reciprocal meiotic recombination (GO:0007131) | 2.79652963 |
119 | response to nitrosative stress (GO:0051409) | 2.79100001 |
120 | neuronal action potential propagation (GO:0019227) | 2.77325031 |
121 | glucosamine-containing compound metabolic process (GO:1901071) | 2.76136099 |
122 | establishment of protein localization to Golgi (GO:0072600) | 2.75030534 |
123 | ribosomal small subunit biogenesis (GO:0042274) | 2.73842070 |
124 | prostate gland growth (GO:0060736) | 2.73756045 |
125 | behavioral response to ethanol (GO:0048149) | 2.73356774 |
126 | leukotriene metabolic process (GO:0006691) | 2.73260533 |
127 | glycine transport (GO:0015816) | 2.69984461 |
128 | rRNA methylation (GO:0031167) | 2.69909199 |
129 | regulation of meiosis I (GO:0060631) | 2.69690432 |
130 | peptidyl-glutamic acid modification (GO:0018200) | 2.68970394 |
131 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.68174831 |
132 | indolalkylamine metabolic process (GO:0006586) | 2.67516297 |
133 | astrocyte development (GO:0014002) | 2.65803242 |
134 | asymmetric protein localization (GO:0008105) | 2.65790463 |
135 | L-phenylalanine metabolic process (GO:0006558) | 2.65631534 |
136 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.65631534 |
137 | microtubule polymerization or depolymerization (GO:0031109) | 2.64850185 |
138 | male meiosis I (GO:0007141) | 2.64826165 |
139 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.63770643 |
140 | defense response to fungus (GO:0050832) | 2.63689661 |
141 | tryptophan metabolic process (GO:0006568) | 2.62603288 |
142 | catechol-containing compound biosynthetic process (GO:0009713) | 2.62202811 |
143 | catecholamine biosynthetic process (GO:0042423) | 2.62202811 |
144 | regulation of catecholamine metabolic process (GO:0042069) | 2.60980008 |
145 | regulation of dopamine metabolic process (GO:0042053) | 2.60980008 |
146 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.60565803 |
147 | cellular ketone body metabolic process (GO:0046950) | 2.60104681 |
148 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.59875662 |
149 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.59034449 |
150 | glutathione biosynthetic process (GO:0006750) | 2.58792430 |
151 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.57591651 |
152 | myelination in peripheral nervous system (GO:0022011) | 2.57559078 |
153 | peripheral nervous system axon ensheathment (GO:0032292) | 2.57559078 |
154 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.57351976 |
155 | positive regulation of pseudopodium assembly (GO:0031274) | 2.57214372 |
156 | RNA destabilization (GO:0050779) | 2.56935895 |
157 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.56498375 |
158 | receptor catabolic process (GO:0032801) | 2.56288881 |
159 | neurotransmitter catabolic process (GO:0042135) | 2.56250363 |
160 | regulation of glutamate secretion (GO:0014048) | 2.56235852 |
161 | response to superoxide (GO:0000303) | 2.55670954 |
162 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.55592637 |
163 | glutamate receptor signaling pathway (GO:0007215) | 2.55409706 |
164 | single strand break repair (GO:0000012) | 2.55361372 |
165 | cholesterol biosynthetic process (GO:0006695) | 2.53867469 |
166 | sperm motility (GO:0030317) | 2.53789237 |
167 | positive regulation of chemokine secretion (GO:0090197) | 2.52277758 |
168 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.51388291 |
169 | mitochondrion transport along microtubule (GO:0047497) | 2.51031076 |
170 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.51031076 |
171 | cerebellar Purkinje cell layer development (GO:0021680) | 2.50510213 |
172 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.50038911 |
173 | neuron recognition (GO:0008038) | 2.47852813 |
174 | membrane tubulation (GO:0097320) | 2.47426599 |
175 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.47232963 |
176 | ER overload response (GO:0006983) | 2.47190245 |
177 | neuron cell-cell adhesion (GO:0007158) | 2.46793578 |
178 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.46281513 |
179 | protein localization to endosome (GO:0036010) | 2.44442904 |
180 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.43494269 |
181 | regulation of heat generation (GO:0031650) | 2.43096607 |
182 | metanephric nephron tubule development (GO:0072234) | 2.42964759 |
183 | metanephric tubule development (GO:0072170) | 2.42964759 |
184 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.42089299 |
185 | negative regulation of chemokine production (GO:0032682) | 2.41927980 |
186 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.39994218 |
187 | regulation of collateral sprouting (GO:0048670) | 2.39981280 |
188 | glycerophospholipid catabolic process (GO:0046475) | 2.38822565 |
189 | protein K11-linked deubiquitination (GO:0035871) | 2.38101913 |
190 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.37609449 |
191 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.37121514 |
192 | axon development (GO:0061564) | 2.36958505 |
193 | amino acid import (GO:0043090) | 2.35804692 |
194 | response to lipoprotein particle (GO:0055094) | 2.35599837 |
195 | neuron remodeling (GO:0016322) | 2.32543458 |
196 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.32192112 |
197 | primary alcohol catabolic process (GO:0034310) | 2.31859830 |
198 | sterol biosynthetic process (GO:0016126) | 2.31745770 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28931343 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.38764196 |
3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.19511524 |
4 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.85006901 |
5 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.66039431 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52336861 |
7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.50909775 |
8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.34010123 |
9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.26574363 |
10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21589071 |
11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.17330368 |
12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14399973 |
13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.14208191 |
14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.13672018 |
15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.13672018 |
16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05796559 |
17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02560837 |
18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.00825954 |
19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00581715 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99138561 |
21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.96051557 |
22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95001379 |
23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.91357371 |
24 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88036293 |
25 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87645276 |
26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87549796 |
27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.87334513 |
28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87001866 |
29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81083150 |
30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.80993839 |
31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70344579 |
32 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.69070628 |
33 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66723500 |
34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.62133344 |
35 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.61251520 |
36 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.61251520 |
37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60800212 |
38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.59697788 |
39 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.59697788 |
40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56230454 |
41 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56230454 |
42 | STAT3_23295773_ChIP-Seq_U87_Human | 1.56204943 |
43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55397589 |
44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54774031 |
45 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.54658356 |
46 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.51990495 |
47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48062602 |
48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.46421774 |
49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.44286773 |
50 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.44211619 |
51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.43379197 |
52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.40554931 |
53 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.39799538 |
54 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.38196912 |
55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36536177 |
56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.36129542 |
57 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.35703969 |
58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35211260 |
59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.34717751 |
60 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.32186697 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31695442 |
62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31291153 |
63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.30845247 |
64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.29138801 |
65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.29119519 |
66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28850267 |
67 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.28575047 |
68 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.27300751 |
69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27163202 |
70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27097961 |
71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27097961 |
72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26319347 |
73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26095217 |
74 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25982813 |
75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.25933296 |
76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.25177109 |
77 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.25034180 |
78 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.24328153 |
79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24156626 |
80 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24116043 |
81 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.23251266 |
82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23116658 |
83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22375341 |
84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22141860 |
85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.21291048 |
86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21281181 |
87 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19976233 |
88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19910988 |
89 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.19298230 |
90 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18298008 |
91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16893599 |
92 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16893599 |
93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16019663 |
94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15697536 |
95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15209718 |
96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14922488 |
97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.14468359 |
98 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.13547860 |
99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13364280 |
100 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13159623 |
101 | NCOR_22424771_ChIP-Seq_293T_Human | 1.12903497 |
102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12795052 |
103 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.12736180 |
104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12075471 |
105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11904007 |
106 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10885223 |
107 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10830405 |
108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10258930 |
109 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10017042 |
110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09164894 |
111 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08526208 |
112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08232218 |
113 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07971985 |
114 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.07909698 |
115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07109208 |
116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06975407 |
117 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.06828624 |
118 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06271553 |
119 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05347645 |
120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05195571 |
121 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04715189 |
122 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04562464 |
123 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04433463 |
124 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04264438 |
125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03888049 |
126 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03595862 |
127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03479486 |
128 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03362874 |
129 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03309325 |
130 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03190306 |
131 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02505885 |
132 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02224877 |
133 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01977802 |
134 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.01614925 |
135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01215693 |
136 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00851951 |
137 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99875760 |
138 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99415402 |
139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98577794 |
140 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98229679 |
141 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97843688 |
142 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97771572 |
143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96200624 |
144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95834390 |
145 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94681271 |
146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94072805 |
147 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92314296 |
148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91235770 |
149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90768834 |
150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90724086 |
151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.90091822 |
152 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.87574031 |
153 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85542976 |
154 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.84934690 |
155 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83702050 |
156 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83625909 |
157 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83181775 |
158 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82313258 |
159 | AR_25329375_ChIP-Seq_VCAP_Human | 0.81513543 |
160 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.81487047 |
161 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81439335 |
162 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.81419847 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008961_abnormal_basal_metabolism | 4.31927090 |
2 | MP0000920_abnormal_myelination | 4.10816150 |
3 | MP0003950_abnormal_plasma_membrane | 4.00091765 |
4 | MP0005670_abnormal_white_adipose | 3.82320109 |
5 | MP0004043_abnormal_pH_regulation | 3.66674025 |
6 | MP0005085_abnormal_gallbladder_physiolo | 3.51364552 |
7 | MP0005365_abnormal_bile_salt | 3.33566228 |
8 | MP0003195_calcinosis | 3.24998783 |
9 | MP0003252_abnormal_bile_duct | 3.14517920 |
10 | MP0008057_abnormal_DNA_replication | 3.10644147 |
11 | MP0003880_abnormal_central_pattern | 2.85411365 |
12 | MP0005645_abnormal_hypothalamus_physiol | 2.84443722 |
13 | MP0004859_abnormal_synaptic_plasticity | 2.77780735 |
14 | MP0005171_absent_coat_pigmentation | 2.74360894 |
15 | MP0003183_abnormal_peptide_metabolism | 2.68159864 |
16 | MP0003690_abnormal_glial_cell | 2.64302515 |
17 | MP0001984_abnormal_olfaction | 2.59394508 |
18 | MP0002064_seizures | 2.50850805 |
19 | MP0008058_abnormal_DNA_repair | 2.49209963 |
20 | MP0008877_abnormal_DNA_methylation | 2.47219347 |
21 | MP0002909_abnormal_adrenal_gland | 2.47034767 |
22 | MP0004270_analgesia | 2.40632860 |
23 | MP0002254_reproductive_system_inflammat | 2.39559447 |
24 | MP0002272_abnormal_nervous_system | 2.36817741 |
25 | MP0005379_endocrine/exocrine_gland_phen | 2.28897797 |
26 | MP0001529_abnormal_vocalization | 2.26535742 |
27 | MP0004019_abnormal_vitamin_homeostasis | 2.24806739 |
28 | MP0002735_abnormal_chemical_nociception | 2.19581269 |
29 | MP0010329_abnormal_lipoprotein_level | 2.05471937 |
30 | MP0003635_abnormal_synaptic_transmissio | 2.04423754 |
31 | MP0008260_abnormal_autophagy | 2.04365821 |
32 | MP0005377_hearing/vestibular/ear_phenot | 2.03691951 |
33 | MP0003878_abnormal_ear_physiology | 2.03691951 |
34 | MP0009745_abnormal_behavioral_response | 2.01473582 |
35 | MP0010234_abnormal_vibrissa_follicle | 2.00447610 |
36 | MP0009046_muscle_twitch | 2.00415489 |
37 | MP0005423_abnormal_somatic_nervous | 2.00254467 |
38 | MP0001486_abnormal_startle_reflex | 1.98060262 |
39 | MP0005451_abnormal_body_composition | 1.91524720 |
40 | MP0001501_abnormal_sleep_pattern | 1.91427492 |
41 | MP0002734_abnormal_mechanical_nocicepti | 1.90126008 |
42 | MP0003329_amyloid_beta_deposits | 1.86190185 |
43 | MP0001346_abnormal_lacrimal_gland | 1.81341059 |
44 | MP0005083_abnormal_biliary_tract | 1.80428990 |
45 | MP0004742_abnormal_vestibular_system | 1.74091422 |
46 | MP0001905_abnormal_dopamine_level | 1.72850168 |
47 | MP0003806_abnormal_nucleotide_metabolis | 1.72580175 |
48 | MP0001970_abnormal_pain_threshold | 1.72098614 |
49 | MP0006082_CNS_inflammation | 1.70112646 |
50 | MP0004142_abnormal_muscle_tone | 1.65501094 |
51 | MP0003634_abnormal_glial_cell | 1.65433621 |
52 | MP0003718_maternal_effect | 1.65073053 |
53 | MP0009115_abnormal_fat_cell | 1.59406420 |
54 | MP0002876_abnormal_thyroid_physiology | 1.58067190 |
55 | MP0002733_abnormal_thermal_nociception | 1.57782838 |
56 | MP0001968_abnormal_touch/_nociception | 1.54724710 |
57 | MP0005409_darkened_coat_color | 1.54172352 |
58 | MP0010386_abnormal_urinary_bladder | 1.53068481 |
59 | MP0000778_abnormal_nervous_system | 1.50705659 |
60 | MP0002063_abnormal_learning/memory/cond | 1.49932012 |
61 | MP0000516_abnormal_urinary_system | 1.47672810 |
62 | MP0005367_renal/urinary_system_phenotyp | 1.47672810 |
63 | MP0001765_abnormal_ion_homeostasis | 1.47173598 |
64 | MP0003136_yellow_coat_color | 1.46647162 |
65 | MP0004885_abnormal_endolymph | 1.46561941 |
66 | MP0009840_abnormal_foam_cell | 1.40704156 |
67 | MP0003123_paternal_imprinting | 1.40208414 |
68 | MP0003633_abnormal_nervous_system | 1.36938060 |
69 | MP0001348_abnormal_lacrimal_gland | 1.34266251 |
70 | MP0009697_abnormal_copulation | 1.33473860 |
71 | MP0003631_nervous_system_phenotype | 1.32919162 |
72 | MP0002638_abnormal_pupillary_reflex | 1.31952405 |
73 | MP0001440_abnormal_grooming_behavior | 1.28983548 |
74 | MP0002572_abnormal_emotion/affect_behav | 1.27980639 |
75 | MP0003698_abnormal_male_reproductive | 1.23649072 |
76 | MP0001756_abnormal_urination | 1.22210545 |
77 | MP0008569_lethality_at_weaning | 1.21979095 |
78 | MP0001502_abnormal_circadian_rhythm | 1.16052894 |
79 | MP0003075_altered_response_to | 1.15921741 |
80 | MP0004924_abnormal_behavior | 1.14065434 |
81 | MP0005386_behavior/neurological_phenoty | 1.14065434 |
82 | MP0010678_abnormal_skin_adnexa | 1.13694024 |
83 | MP0009643_abnormal_urine_homeostasis | 1.13283912 |
84 | MP0001986_abnormal_taste_sensitivity | 1.11024576 |
85 | MP0005310_abnormal_salivary_gland | 1.10265092 |
86 | MP0004510_myositis | 1.10094411 |
87 | MP0008874_decreased_physiological_sensi | 1.08082299 |
88 | MP0002067_abnormal_sensory_capabilities | 1.07962766 |
89 | MP0005220_abnormal_exocrine_pancreas | 1.07215542 |
90 | MP0005266_abnormal_metabolism | 1.06913257 |
91 | MP0005448_abnormal_energy_balance | 1.06699520 |
92 | MP0005410_abnormal_fertilization | 1.06345798 |
93 | MP0003121_genomic_imprinting | 1.05730209 |
94 | MP0006276_abnormal_autonomic_nervous | 1.04870104 |
95 | MP0000647_abnormal_sebaceous_gland | 1.04748050 |
96 | MP0000604_amyloidosis | 1.04488325 |
97 | MP0004381_abnormal_hair_follicle | 1.04125830 |
98 | MP0002066_abnormal_motor_capabilities/c | 1.03252703 |
99 | MP0005167_abnormal_blood-brain_barrier | 1.02222607 |
100 | MP0001929_abnormal_gametogenesis | 1.02002584 |
101 | MP0008789_abnormal_olfactory_epithelium | 1.01679058 |
102 | MP0005332_abnormal_amino_acid | 1.01451333 |
103 | MP0002229_neurodegeneration | 1.01372059 |
104 | MP0002295_abnormal_pulmonary_circulatio | 1.00419663 |
105 | MP0005395_other_phenotype | 1.00380296 |
106 | MP0001177_atelectasis | 0.99942164 |
107 | MP0005636_abnormal_mineral_homeostasis | 0.99809086 |
108 | MP0001944_abnormal_pancreas_morphology | 0.98829945 |
109 | MP0005058_abnormal_lysosome_morphology | 0.98687219 |
110 | MP0003632_abnormal_nervous_system | 0.98490252 |
111 | MP0000003_abnormal_adipose_tissue | 0.98423028 |
112 | MP0005408_hypopigmentation | 0.96376928 |
113 | MP0003959_abnormal_lean_body | 0.95685649 |
114 | MP0002822_catalepsy | 0.94995696 |
115 | MP0002693_abnormal_pancreas_physiology | 0.94764640 |
116 | MP0000955_abnormal_spinal_cord | 0.94611597 |
117 | MP0000538_abnormal_urinary_bladder | 0.91087606 |
118 | MP0003453_abnormal_keratinocyte_physiol | 0.91075798 |
119 | MP0002882_abnormal_neuron_morphology | 0.90347882 |
120 | * MP0008872_abnormal_physiological_respon | 0.89318363 |
121 | MP0002184_abnormal_innervation | 0.88249641 |
122 | MP0002118_abnormal_lipid_homeostasis | 0.87031105 |
123 | MP0003011_delayed_dark_adaptation | 0.86379839 |
124 | MP0002090_abnormal_vision | 0.86118204 |
125 | MP0001485_abnormal_pinna_reflex | 0.85803045 |
126 | MP0002332_abnormal_exercise_endurance | 0.85776269 |
127 | MP0000569_abnormal_digit_pigmentation | 0.84835555 |
128 | MP0000230_abnormal_systemic_arterial | 0.84728653 |
129 | MP0005535_abnormal_body_temperature | 0.84114900 |
130 | MP0000383_abnormal_hair_follicle | 0.83371701 |
131 | MP0000639_abnormal_adrenal_gland | 0.82600818 |
132 | MP0005499_abnormal_olfactory_system | 0.82173219 |
133 | MP0005394_taste/olfaction_phenotype | 0.82173219 |
134 | MP0009780_abnormal_chondrocyte_physiolo | 0.81284433 |
135 | MP0003724_increased_susceptibility_to | 0.80666509 |
136 | MP0002078_abnormal_glucose_homeostasis | 0.79706927 |
137 | MP0003828_pulmonary_edema | 0.78138865 |
138 | MP0002160_abnormal_reproductive_system | 0.78138118 |
139 | MP0004134_abnormal_chest_morphology | 0.76602723 |
140 | MP0003879_abnormal_hair_cell | 0.76384044 |
141 | MP0000026_abnormal_inner_ear | 0.74789626 |
142 | MP0002210_abnormal_sex_determination | 0.74064552 |
143 | MP0002136_abnormal_kidney_physiology | 0.73503665 |
144 | MP0005551_abnormal_eye_electrophysiolog | 0.72317522 |
145 | MP0005164_abnormal_response_to | 0.71745215 |
146 | MP0001963_abnormal_hearing_physiology | 0.71368588 |
147 | MP0005195_abnormal_posterior_eye | 0.71146519 |
148 | MP0003122_maternal_imprinting | 0.70782668 |
149 | MP0002970_abnormal_white_adipose | 0.70404257 |
150 | MP0002736_abnormal_nociception_after | 0.70168794 |
151 | MP0004811_abnormal_neuron_physiology | 0.70111887 |
152 | MP0002163_abnormal_gland_morphology | 0.69289632 |
153 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68787192 |
154 | MP0003787_abnormal_imprinting | 0.68369602 |
155 | MP0000579_abnormal_nail_morphology | 0.68239603 |
156 | MP0005623_abnormal_meninges_morphology | 0.67004906 |
157 | MP0000537_abnormal_urethra_morphology | 0.66238882 |
158 | MP0002098_abnormal_vibrissa_morphology | 0.66057295 |
159 | MP0000613_abnormal_salivary_gland | 0.65686230 |
160 | MP0009765_abnormal_xenobiotic_induced | 0.65445705 |
161 | MP0002168_other_aberrant_phenotype | 0.63742553 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Peripheral hypomyelination (HP:0007182) | 6.64934964 |
2 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 5.33519163 |
3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.10755455 |
4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.10755455 |
5 | Axonal loss (HP:0003447) | 4.94426327 |
6 | Onion bulb formation (HP:0003383) | 4.59020837 |
7 | Neurofibrillary tangles (HP:0002185) | 4.49370838 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.36200181 |
9 | Peripheral demyelination (HP:0011096) | 4.23562953 |
10 | Myokymia (HP:0002411) | 4.11706626 |
11 | Progressive cerebellar ataxia (HP:0002073) | 4.06287472 |
12 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.90730994 |
13 | Abnormality of the corticospinal tract (HP:0002492) | 3.86807330 |
14 | Hyperaldosteronism (HP:0000859) | 3.83878435 |
15 | Focal motor seizures (HP:0011153) | 3.76761564 |
16 | Alacrima (HP:0000522) | 3.76133761 |
17 | Medial flaring of the eyebrow (HP:0010747) | 3.75261090 |
18 | Clumsiness (HP:0002312) | 3.73704817 |
19 | Abnormality of chloride homeostasis (HP:0011422) | 3.60999261 |
20 | Neoplasm of the adrenal cortex (HP:0100641) | 3.57716112 |
21 | Bilateral microphthalmos (HP:0007633) | 3.49345511 |
22 | Prostate neoplasm (HP:0100787) | 3.39931621 |
23 | Cerebral inclusion bodies (HP:0100314) | 3.37484372 |
24 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.37061066 |
25 | Hypoplasia of the fovea (HP:0007750) | 3.34237561 |
26 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.34237561 |
27 | Congenital sensorineural hearing impairment (HP:0008527) | 3.30244338 |
28 | Parakeratosis (HP:0001036) | 3.30227036 |
29 | Abnormal auditory evoked potentials (HP:0006958) | 3.29191373 |
30 | Genital tract atresia (HP:0001827) | 3.22287473 |
31 | Vaginal atresia (HP:0000148) | 3.21140334 |
32 | Spastic gait (HP:0002064) | 3.15184042 |
33 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.10527694 |
34 | Hyperkalemia (HP:0002153) | 3.09404714 |
35 | Gait imbalance (HP:0002141) | 3.08823878 |
36 | Attenuation of retinal blood vessels (HP:0007843) | 3.07330235 |
37 | Aplasia of the phalanges of the hand (HP:0009802) | 3.05638203 |
38 | Aplasia involving bones of the extremities (HP:0009825) | 3.05638203 |
39 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.05638203 |
40 | Congenital primary aphakia (HP:0007707) | 3.03013384 |
41 | Abnormality of the prostate (HP:0008775) | 3.01509655 |
42 | Renal Fanconi syndrome (HP:0001994) | 3.00882402 |
43 | Prolonged partial thromboplastin time (HP:0003645) | 2.99359668 |
44 | Focal seizures (HP:0007359) | 2.98203613 |
45 | Neuroendocrine neoplasm (HP:0100634) | 2.91665207 |
46 | Confusion (HP:0001289) | 2.91535661 |
47 | Cerebral hypomyelination (HP:0006808) | 2.90879899 |
48 | Decreased motor nerve conduction velocity (HP:0003431) | 2.83214869 |
49 | Genetic anticipation (HP:0003743) | 2.81861147 |
50 | Abnormality of the intrinsic pathway (HP:0010989) | 2.80300202 |
51 | Diaphragmatic weakness (HP:0009113) | 2.78968974 |
52 | Poor coordination (HP:0002370) | 2.78576592 |
53 | Pheochromocytoma (HP:0002666) | 2.77851376 |
54 | Protruding tongue (HP:0010808) | 2.77087177 |
55 | Hyperventilation (HP:0002883) | 2.72549526 |
56 | Metabolic alkalosis (HP:0200114) | 2.71770183 |
57 | Exotropia (HP:0000577) | 2.71277666 |
58 | Short tibia (HP:0005736) | 2.69627977 |
59 | Blue irides (HP:0000635) | 2.68127608 |
60 | Nephrogenic diabetes insipidus (HP:0009806) | 2.67210304 |
61 | Mutism (HP:0002300) | 2.61491585 |
62 | Abnormality of the renal cortex (HP:0011035) | 2.61323294 |
63 | Generalized tonic-clonic seizures (HP:0002069) | 2.60498412 |
64 | Scanning speech (HP:0002168) | 2.60318164 |
65 | Osteomalacia (HP:0002749) | 2.59243826 |
66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.57781956 |
67 | White forelock (HP:0002211) | 2.57518248 |
68 | Decreased lacrimation (HP:0000633) | 2.52899131 |
69 | Abnormality of vitamin metabolism (HP:0100508) | 2.52406844 |
70 | Supranuclear gaze palsy (HP:0000605) | 2.52359370 |
71 | Muscle fiber splitting (HP:0003555) | 2.51097945 |
72 | Hypothermia (HP:0002045) | 2.49503562 |
73 | Megalencephaly (HP:0001355) | 2.48247841 |
74 | Abnormality of potassium homeostasis (HP:0011042) | 2.47753652 |
75 | Stridor (HP:0010307) | 2.45567340 |
76 | Absent speech (HP:0001344) | 2.45416687 |
77 | Tubulointerstitial fibrosis (HP:0005576) | 2.45222793 |
78 | Pendular nystagmus (HP:0012043) | 2.42513390 |
79 | Dialeptic seizures (HP:0011146) | 2.42372316 |
80 | Prolonged neonatal jaundice (HP:0006579) | 2.41601281 |
81 | Opisthotonus (HP:0002179) | 2.41570967 |
82 | Foot dorsiflexor weakness (HP:0009027) | 2.41475789 |
83 | Renal salt wasting (HP:0000127) | 2.41168190 |
84 | Patchy hypopigmentation of hair (HP:0011365) | 2.41003125 |
85 | Broad alveolar ridges (HP:0000187) | 2.38286586 |
86 | Obstructive sleep apnea (HP:0002870) | 2.38190499 |
87 | Dysmetria (HP:0001310) | 2.38056902 |
88 | Hypoproteinemia (HP:0003075) | 2.34586008 |
89 | Cerebral hemorrhage (HP:0001342) | 2.32264352 |
90 | Hypoalbuminemia (HP:0003073) | 2.31689735 |
91 | Abnormal albumin level (HP:0012116) | 2.31689735 |
92 | Tubulointerstitial abnormality (HP:0001969) | 2.31336427 |
93 | Torticollis (HP:0000473) | 2.30415370 |
94 | Abnormality of the fovea (HP:0000493) | 2.30317789 |
95 | Increased cerebral lipofuscin (HP:0011813) | 2.28145554 |
96 | Abnormality of the nasal septum (HP:0000419) | 2.27650160 |
97 | Ureteral obstruction (HP:0006000) | 2.26681250 |
98 | Hepatosplenomegaly (HP:0001433) | 2.26675575 |
99 | Reduced antithrombin III activity (HP:0001976) | 2.25873328 |
100 | Ankle clonus (HP:0011448) | 2.25116032 |
101 | Episodic fever (HP:0001954) | 2.23758435 |
102 | Colon cancer (HP:0003003) | 2.22836245 |
103 | Leukodystrophy (HP:0002415) | 2.21688818 |
104 | Tubulointerstitial nephritis (HP:0001970) | 2.19990033 |
105 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.18896128 |
106 | Insidious onset (HP:0003587) | 2.18843414 |
107 | Termporal pattern (HP:0011008) | 2.18843414 |
108 | Pancreatic cysts (HP:0001737) | 2.18609282 |
109 | Hyponatremia (HP:0002902) | 2.16288972 |
110 | Abnormality of renal resorption (HP:0011038) | 2.16068142 |
111 | Hyperactive renin-angiotensin system (HP:0000841) | 2.15887695 |
112 | Abnormality of the foot musculature (HP:0001436) | 2.15173877 |
113 | Broad-based gait (HP:0002136) | 2.14852638 |
114 | Truncal ataxia (HP:0002078) | 2.13376255 |
115 | Abnormality of vitamin B metabolism (HP:0004340) | 2.13350194 |
116 | Small hand (HP:0200055) | 2.12811012 |
117 | Abnormality of the renal medulla (HP:0100957) | 2.11853825 |
118 | Choreoathetosis (HP:0001266) | 2.11797964 |
119 | Molar tooth sign on MRI (HP:0002419) | 2.11383803 |
120 | Abnormality of midbrain morphology (HP:0002418) | 2.11383803 |
121 | Limb dystonia (HP:0002451) | 2.11037968 |
122 | Increased hepatocellular lipid droplets (HP:0006565) | 2.09834225 |
123 | Thoracolumbar scoliosis (HP:0002944) | 2.08491680 |
124 | Conical tooth (HP:0000698) | 2.08236368 |
125 | Decreased circulating renin level (HP:0003351) | 2.07841499 |
126 | Birth length less than 3rd percentile (HP:0003561) | 2.05451137 |
127 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01980622 |
128 | 3-Methylglutaconic aciduria (HP:0003535) | 2.00781250 |
129 | Sleep apnea (HP:0010535) | 2.00432267 |
130 | Lower limb muscle weakness (HP:0007340) | 1.99613265 |
131 | Generalized hypopigmentation of hair (HP:0011358) | 1.99316522 |
132 | Cutaneous photosensitivity (HP:0000992) | 1.98533426 |
133 | Hypophosphatemic rickets (HP:0004912) | 1.98437043 |
134 | Split foot (HP:0001839) | 1.98125507 |
135 | Cystic liver disease (HP:0006706) | 1.97940585 |
136 | Large for gestational age (HP:0001520) | 1.97372248 |
137 | Lipid accumulation in hepatocytes (HP:0006561) | 1.97018063 |
138 | Hyporeflexia of lower limbs (HP:0002600) | 1.96993340 |
139 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.96190722 |
140 | Hyperphosphaturia (HP:0003109) | 1.95580953 |
141 | Thickened helices (HP:0000391) | 1.95194162 |
142 | Abnormality of macrophages (HP:0004311) | 1.94924862 |
143 | Hypokalemic alkalosis (HP:0001949) | 1.93058670 |
144 | CNS hypomyelination (HP:0003429) | 1.93019959 |
145 | Hypokalemia (HP:0002900) | 1.92811571 |
146 | Polyuria (HP:0000103) | 1.92181395 |
147 | Anxiety (HP:0000739) | 1.91965715 |
148 | Conjugated hyperbilirubinemia (HP:0002908) | 1.90687043 |
149 | Infantile muscular hypotonia (HP:0008947) | 1.90512028 |
150 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.90207139 |
151 | Ureteral stenosis (HP:0000071) | 1.89954215 |
152 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.89193928 |
153 | Intellectual disability, progressive (HP:0006887) | 1.88912869 |
154 | Oligodontia (HP:0000677) | 1.88728557 |
155 | Gaze-evoked nystagmus (HP:0000640) | 1.87882354 |
156 | Hammertoe (HP:0001765) | 1.87064772 |
157 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.86859949 |
158 | Abnormality of male internal genitalia (HP:0000022) | 1.85021705 |
159 | Intellectual disability, moderate (HP:0002342) | 1.84488907 |
160 | Abnormal protein glycosylation (HP:0012346) | 1.83823570 |
161 | Abnormal glycosylation (HP:0012345) | 1.83823570 |
162 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83823570 |
163 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83823570 |
164 | Xerostomia (HP:0000217) | 1.82773672 |
165 | Type II lissencephaly (HP:0007260) | 1.82300394 |
166 | Proximal tubulopathy (HP:0000114) | 1.82298573 |
167 | Tubular atrophy (HP:0000092) | 1.82150978 |
168 | Joint hemorrhage (HP:0005261) | 1.81872972 |
169 | Progressive neurologic deterioration (HP:0002344) | 1.81627335 |
170 | Generalized myoclonic seizures (HP:0002123) | 1.81625095 |
171 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.81440018 |
172 | Absent/shortened dynein arms (HP:0200106) | 1.81379385 |
173 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.81379385 |
174 | Stomach cancer (HP:0012126) | 1.81264394 |
175 | Fair hair (HP:0002286) | 1.80969098 |
176 | Retinitis pigmentosa (HP:0000510) | 1.80469953 |
177 | Distal sensory impairment (HP:0002936) | 1.80293186 |
178 | Abnormality of salivation (HP:0100755) | 1.79817402 |
179 | Intention tremor (HP:0002080) | 1.79272115 |
180 | Abnormal ciliary motility (HP:0012262) | 1.78907284 |
181 | Excessive salivation (HP:0003781) | 1.78339268 |
182 | Drooling (HP:0002307) | 1.78339268 |
183 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.77288063 |
184 | Cholecystitis (HP:0001082) | 1.76741950 |
185 | Abnormal gallbladder physiology (HP:0012438) | 1.76741950 |
186 | Hemiparesis (HP:0001269) | 1.75596285 |
187 | Morphological abnormality of the inner ear (HP:0011390) | 1.74968598 |
188 | Sensory axonal neuropathy (HP:0003390) | 1.74733762 |
189 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.74543260 |
190 | Neoplasm of the adrenal gland (HP:0100631) | 1.74460141 |
191 | Intrahepatic cholestasis (HP:0001406) | 1.74244827 |
192 | Abnormal hair whorl (HP:0010721) | 1.74081422 |
193 | Visual hallucinations (HP:0002367) | 1.71428934 |
194 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71057920 |
195 | Focal dystonia (HP:0004373) | 1.70622953 |
196 | Spastic paraparesis (HP:0002313) | 1.70597798 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CCNB1 | 5.50179742 |
2 | TAF1 | 5.08920830 |
3 | VRK2 | 4.63328165 |
4 | STK39 | 4.59752275 |
5 | NEK2 | 4.49476317 |
6 | SMG1 | 4.29732005 |
7 | MET | 3.62764171 |
8 | FGR | 3.54074041 |
9 | CAMKK2 | 3.44460281 |
10 | EPHB1 | 3.40201283 |
11 | INSRR | 3.22777182 |
12 | NUAK1 | 3.17995944 |
13 | OXSR1 | 3.17203281 |
14 | CASK | 3.00074281 |
15 | PKN1 | 2.99789352 |
16 | CAMK1D | 2.65609695 |
17 | DMPK | 2.42196957 |
18 | GRK7 | 2.32189792 |
19 | CAMK1G | 2.08398374 |
20 | NEK6 | 1.97583443 |
21 | UHMK1 | 1.89351889 |
22 | CSF1R | 1.87567571 |
23 | ADRBK2 | 1.80262649 |
24 | WNK3 | 1.80115032 |
25 | EPHA2 | 1.77474016 |
26 | FGFR2 | 1.75245594 |
27 | CAMK2B | 1.74283979 |
28 | MAPKAPK5 | 1.71138637 |
29 | MAP3K4 | 1.67114610 |
30 | MARK1 | 1.66105994 |
31 | PAK6 | 1.65454523 |
32 | PTK2B | 1.65130989 |
33 | WNK4 | 1.59635646 |
34 | NTRK1 | 1.57215433 |
35 | MAP3K6 | 1.55997222 |
36 | MAP3K13 | 1.55266562 |
37 | LMTK2 | 1.51836102 |
38 | BMX | 1.49131530 |
39 | PHKG1 | 1.48475733 |
40 | PHKG2 | 1.48475733 |
41 | WNK1 | 1.41785715 |
42 | MST1R | 1.37380064 |
43 | ROCK2 | 1.37097387 |
44 | MAP3K14 | 1.33589658 |
45 | PINK1 | 1.33359149 |
46 | BCR | 1.32256595 |
47 | CHUK | 1.28847259 |
48 | VRK1 | 1.25753010 |
49 | CDK5 | 1.24547462 |
50 | CDK19 | 1.20995014 |
51 | CAMK2A | 1.20680827 |
52 | RPS6KB2 | 1.19305250 |
53 | CAMK2D | 1.18449328 |
54 | DYRK3 | 1.16435342 |
55 | PAK3 | 1.11599908 |
56 | RIPK4 | 1.08919850 |
57 | CAMK2G | 1.08569049 |
58 | NTRK2 | 1.08029790 |
59 | LATS1 | 1.05845033 |
60 | BMPR2 | 0.99024366 |
61 | EPHA4 | 0.98828292 |
62 | NTRK3 | 0.97413335 |
63 | PIK3CG | 0.97321797 |
64 | CAMK1 | 0.97239947 |
65 | DAPK3 | 0.95847455 |
66 | MAP2K7 | 0.95465894 |
67 | MAP3K9 | 0.92572665 |
68 | PLK4 | 0.92325886 |
69 | PRKCH | 0.90762266 |
70 | MAP3K7 | 0.89739200 |
71 | GRK1 | 0.88744633 |
72 | PRKAA2 | 0.86982661 |
73 | DYRK2 | 0.83778571 |
74 | KSR2 | 0.83769925 |
75 | PTK2 | 0.83401423 |
76 | RPS6KA5 | 0.79621257 |
77 | ACVR1B | 0.78920990 |
78 | CAMKK1 | 0.78539403 |
79 | SGK223 | 0.78201511 |
80 | SGK494 | 0.78201511 |
81 | MAP3K2 | 0.76321198 |
82 | GRK5 | 0.75962469 |
83 | EIF2AK3 | 0.75156168 |
84 | HIPK2 | 0.74236246 |
85 | LIMK1 | 0.73411476 |
86 | ADRBK1 | 0.71555533 |
87 | ARAF | 0.71115536 |
88 | TGFBR2 | 0.70741878 |
89 | PRKCE | 0.68088514 |
90 | CDK9 | 0.68053377 |
91 | TESK2 | 0.67314207 |
92 | PDGFRB | 0.67028840 |
93 | CDK15 | 0.64562575 |
94 | CAMK4 | 0.64277746 |
95 | PDPK1 | 0.64257147 |
96 | PRKCQ | 0.63266135 |
97 | DYRK1A | 0.62835891 |
98 | TRPM7 | 0.62233286 |
99 | MINK1 | 0.62146409 |
100 | CDK18 | 0.61597659 |
101 | MELK | 0.61300697 |
102 | CSNK1G3 | 0.60972274 |
103 | FES | 0.60961870 |
104 | CDK11A | 0.60536551 |
105 | PRKD1 | 0.58477697 |
106 | MARK2 | 0.58407727 |
107 | YES1 | 0.58066472 |
108 | MAP2K2 | 0.57942863 |
109 | PBK | 0.57570873 |
110 | RAF1 | 0.55662390 |
111 | FRK | 0.55157451 |
112 | GSK3A | 0.54141495 |
113 | PRKCG | 0.53861117 |
114 | CDK14 | 0.53558364 |
115 | STK38L | 0.51947487 |
116 | EPHB2 | 0.49928214 |
117 | PRKG1 | 0.49724491 |
118 | SGK2 | 0.49707386 |
119 | MAPK13 | 0.49182814 |
120 | CSNK1A1L | 0.49010231 |
121 | MST4 | 0.47803472 |
122 | MKNK1 | 0.46632998 |
123 | CSNK1G1 | 0.46422069 |
124 | FER | 0.46305524 |
125 | FYN | 0.44137676 |
126 | PRKACB | 0.43729177 |
127 | PLK2 | 0.43706050 |
128 | EGFR | 0.43026361 |
129 | SRC | 0.41465577 |
130 | PAK1 | 0.41294418 |
131 | PNCK | 0.40629612 |
132 | EIF2AK2 | 0.40525974 |
133 | PDK1 | 0.40267028 |
134 | NME1 | 0.39816933 |
135 | BMPR1B | 0.39700102 |
136 | CSNK1A1 | 0.39333948 |
137 | IRAK3 | 0.38405215 |
138 | ROCK1 | 0.38334592 |
139 | BRD4 | 0.38282953 |
140 | INSR | 0.36676048 |
141 | ERBB4 | 0.36544934 |
142 | CSNK1G2 | 0.36278303 |
143 | LRRK2 | 0.34768538 |
144 | TNIK | 0.34741145 |
145 | PIK3CA | 0.34697962 |
146 | PRKG2 | 0.33755991 |
147 | MKNK2 | 0.33313567 |
148 | CSNK1E | 0.33087408 |
149 | RET | 0.32862173 |
150 | ILK | 0.32714010 |
151 | ALK | 0.32382792 |
152 | ICK | 0.31341436 |
153 | MAP4K2 | 0.29911760 |
154 | PRKCI | 0.29195959 |
155 | DAPK1 | 0.28001588 |
156 | SGK1 | 0.26899069 |
157 | MAPK4 | 0.25777253 |
158 | PLK3 | 0.22396796 |
159 | PAK2 | 0.22105447 |
160 | TIE1 | 0.20695334 |
161 | PRKAA1 | 0.19549117 |
162 | ERN1 | 0.18048329 |
163 | CHEK2 | 0.17451742 |
164 | MAP2K4 | 0.15503448 |
165 | STK24 | 0.14192149 |
166 | PRKCA | 0.13533314 |
167 | MAP2K6 | 0.12536029 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 3.90303416 |
2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.43073486 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.12754293 |
4 | Histidine metabolism_Homo sapiens_hsa00340 | 2.82648631 |
5 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.74401482 |
6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.64410554 |
7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.63182207 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61489340 |
9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.59691772 |
10 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.53909179 |
11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.19517473 |
12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.02952322 |
13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97456370 |
14 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.94818955 |
15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.89620502 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84695697 |
17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.83678078 |
18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.82014510 |
19 | Taste transduction_Homo sapiens_hsa04742 | 1.78327666 |
20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.72628903 |
21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.71825275 |
22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.70931488 |
23 | Asthma_Homo sapiens_hsa05310 | 1.66604705 |
24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64483465 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63707821 |
26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.58641932 |
27 | Morphine addiction_Homo sapiens_hsa05032 | 1.56154903 |
28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47925604 |
29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47774590 |
30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.47105215 |
31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.46876111 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44826697 |
33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.42657030 |
34 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40178231 |
35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38167973 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37685084 |
37 | Protein export_Homo sapiens_hsa03060 | 1.37473698 |
38 | Nicotine addiction_Homo sapiens_hsa05033 | 1.37106180 |
39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.32872158 |
40 | Mineral absorption_Homo sapiens_hsa04978 | 1.32193003 |
41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.31734579 |
42 | Ribosome_Homo sapiens_hsa03010 | 1.29984076 |
43 | Salivary secretion_Homo sapiens_hsa04970 | 1.27649424 |
44 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27358830 |
45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.25725336 |
46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22124292 |
47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19561115 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.19360198 |
49 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.18130795 |
50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18062860 |
51 | Long-term depression_Homo sapiens_hsa04730 | 1.17857844 |
52 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15866807 |
53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.14933930 |
54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.14469625 |
55 | Axon guidance_Homo sapiens_hsa04360 | 1.13580173 |
56 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12572503 |
57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10887520 |
58 | Cocaine addiction_Homo sapiens_hsa05030 | 1.10512108 |
59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.09290817 |
60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06850981 |
61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04664366 |
62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03063532 |
63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02956576 |
64 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02275475 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.01793248 |
66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01486799 |
67 | Homologous recombination_Homo sapiens_hsa03440 | 1.00965856 |
68 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00141205 |
69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99627833 |
70 | Phagosome_Homo sapiens_hsa04145 | 0.99575581 |
71 | Renin secretion_Homo sapiens_hsa04924 | 0.97983038 |
72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96170593 |
73 | Lysine degradation_Homo sapiens_hsa00310 | 0.92514478 |
74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90759851 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90419214 |
76 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88040906 |
77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86445801 |
78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.86126933 |
79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.85817532 |
80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.85268259 |
81 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84671782 |
82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83911254 |
83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82053998 |
84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80778975 |
85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80613172 |
86 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79972790 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79402300 |
88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78942915 |
89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78619304 |
90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77223655 |
91 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76930565 |
92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76177739 |
93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.75204937 |
94 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74933994 |
95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74403373 |
96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74007159 |
97 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73310298 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70621435 |
99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69355039 |
100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68552178 |
101 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68375824 |
102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67725706 |
103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67705667 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67069218 |
105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64603411 |
106 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64494726 |
107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62814343 |
108 | Gap junction_Homo sapiens_hsa04540 | 0.61769737 |
109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61758599 |
110 | Insulin secretion_Homo sapiens_hsa04911 | 0.61051737 |
111 | Salmonella infection_Homo sapiens_hsa05132 | 0.60564377 |
112 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60072394 |
113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.60004967 |
114 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58033964 |
115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57521761 |
116 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57505178 |
117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57270541 |
118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57002091 |
119 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56474920 |
120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56404921 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56379934 |
122 | Allograft rejection_Homo sapiens_hsa05330 | 0.55801473 |
123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54813872 |
124 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54518067 |
125 | Lysosome_Homo sapiens_hsa04142 | 0.54019129 |
126 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53661607 |
127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53270667 |
128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51564375 |
129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.50871078 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50672028 |
131 | Phototransduction_Homo sapiens_hsa04744 | 0.50174278 |
132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49721046 |
133 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47810725 |
134 | Prion diseases_Homo sapiens_hsa05020 | 0.46957705 |
135 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46937976 |
136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46633573 |
137 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45327511 |
138 | Tight junction_Homo sapiens_hsa04530 | 0.44928897 |
139 | Amoebiasis_Homo sapiens_hsa05146 | 0.43942031 |
140 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43770398 |
141 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41390861 |
142 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40563665 |
143 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40093339 |
144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.39475502 |
145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39204233 |
146 | Peroxisome_Homo sapiens_hsa04146 | 0.38373005 |
147 | Melanoma_Homo sapiens_hsa05218 | 0.37213437 |
148 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36718469 |
149 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36073213 |
150 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35453200 |
151 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33583706 |